This post in the U.N. Foundation’s “Shot@Life” blog examines how Honduras, “one of the poorest countries in the Western hemisphere,” has achieved “one of the highest vaccination coverage rates in the world, averaging close to 99 percent.” The blog writes, “We wanted to see firsthand how Honduras has achieved such amazing results, so last week Shot@Life traveled there with a U.S. Congressional staff delegation to learn more about their extremely effective immunization programs” and details the vaccination efforts of the rural town La CaÃ±ada (Willingham, 1/23).
In this Washington Post “Davos Diary” blog entry, Kate Roberts, vice president of corporate marketing, communications and advocacy at PSI, writes about what to expect at the World Economic Forum, beginning on January 25 in Davos, Switzerland. Noting that poor health and access to health care can prevent a growing middle-class population from reaching its “full economic potential,” Roberts writes, “The key to changing this scenario will be finding ways to encourage this emerging class of consumers to adopt healthier behaviors, and giving them the means to do so.” She says public-private partnerships are critical to solving these issues.
“Thirty years after AIDS made its deadly debut, a future without the disease is finally within reach,” a Boston Globe editorial states, adding, “But just as science is on the verge of winning the battle, financial resources and political will are flagging.” The editorial details reductions in HIV spending, a Congressional stipulation that U.S. funds cannot be spent on needle-exchange programs, and new science showing how HIV treatment can help people living with the disease live longer and reduce the risk of them spreading the virus.
“The astounding thing about the global abortion debate is not that some people have deeply held views about what a pregnancy is and when a human existence begins” but that “policymakers continue to ignore carefully amassed information about the actual outcome of programs and laws related to sexuality and reproduction,” Marianne MÃ¸llmann, senior policy adviser with Amnesty International’s International Secretariat, writes in this Guardian opinion piece. MÃ¸llmann cites an analysis by the U.S.-based Guttmacher Institute, published in the Lancet last week, which she says has two main conclusions: “first, when governments fail to provide contraception for those who want it, abortion figures stay the same; and second, where abortion is illegal, the procedure is predominantly unsafe.”
The WHO is expected to hold a meeting in February to discuss controversy over recent research on the H5N1 bird flu virus, after the U.S. National Scientific Advisory Board for Biosecurity (NSABB) in December advised the journals Science and Nature to withhold publishing two teams’ research on the virus for fear the information could “fall into the wrong hands,” a commentary in the Economist’s “Babbage” blog states. “In a statement sent to Science, the WHO says that research” into bird flu genetics is “an important tool for global surveillance efforts,” the commentary says.
In this post in Global Health Frontline News’ “Notes From the Field” blog, Kevin Cain, chief of the tuberculosis (TB) branch for a research and public health collaboration between the Kenya Medical Research Institute (KEMRI) and the CDC in Kisumu, Kenya, reports on TB research underway as part of the collaboration. Cain highlights several current research initiatives in Kisumu and concludes, “The world cannot afford another phase of neglect. We know by partnering with governments as well as affected communities in innovative ways more progress can be made improving programs and the tools available for diagnosing, treating, and preventing TB, and lives will be saved” (1/20).
This post in the Foreign Policy Association blog discusses reports from earlier this month of “an emerging strain of ‘totally drug-resistant’ tuberculosis (TDR-TB)” in India, which the Indian government last week denied, “arguing that the 12 cases were in fact extensively drug resistant (XDR).” The blog states, “Whether or not it’s fair to use the TDR moniker, drug resistance is a serious, emerging issue that may very well define the next stage of global health,” concluding, “We are reaching a turning point, one at which some drug resistant pathogens are on the cusp of shifting from a handful of cases, an endemic, to a bigger, epidemic or even pandemic problem. Now is the time to initiate discussions on what the global community will do to stem drug resistance” (Robinson, 1/21).
A funding shortfall led the Global Fund to Fight AIDS, Tuberculosis and Malaria to announce in November that “it won’t make any grants to fund programs for at least two years,” a Deseret News editorial notes and calls on the U.S. to take a leadership position in saving the fund. The editorial states, “Few worldwide initiatives have the success record of the Global Fund …, but those breakthroughs may not have much chance to save many lives,” and notes that the non-profit lobbying group “Results is calling for the Obama administration to assemble an emergency meeting of donor nations this spring to find ways to ensure that the fund and its programs are able to continue and to provide new medicines where they are needed most.”
“In 2012 there will be a major strategic shift in global health, away from development and towards sustainability,” a Lancet editorial states. “Since 2000, the Millennium Development Goals (MDGs), driven by a macroeconomic diagnosis of global poverty, have focused on investment in a small number of diseases as the most effective approach to decrease poverty, … [b]ut this approach is now delivering diminishing returns,” because of emerging challenges such as non-communicable diseases (NCDs), climate change, and financial security, as well as a heightened focus on integration and accountability, the editorial says.
“An international debate over whether to censor new research on bird flu may soon prove academic, as other laboratories close in on similar findings showing how one of the most deadly viruses could mutate to be transmitted from one person to another,” Reuters reports. Last year, two teams of researchers reported study results “that showed how the H5N1 [bird flu] virus can be transmitted through airborne droplets between ferrets, a model for studying influenza in humans,” and the findings prompted the U.S. National Science Advisory Board for Biosecurity (NSABB) in December to advise “two leading journals, Nature and Science, to withhold details of the research for fear it could be used by bioterrorists,” the news service writes.